Gary Holland to Clinical Trials as Topic
This is a "connection" page, showing publications Gary Holland has written about Clinical Trials as Topic.
Connection Strength
0.184
-
Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis. Orphanet J Rare Dis. 2015 Aug 19; 10:97.
Score: 0.114
-
Therapeutic decisions: informed choices in a changing clinical environment. Am J Ophthalmol. 1999 Mar; 127(3):327-8.
Score: 0.036
-
A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group. Arch Ophthalmol. 1989 Dec; 107(12):1759-66.
Score: 0.019
-
Clinician versus reading center assessment of cytomegalovirus retinitis lesion size. Ophthalmology. 2005 Apr; 112(4):559-66.
Score: 0.014